Menu Search
Equities

GN Store Nord A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GN:CPH

GN Store Nord A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)97.50
  • Today's Change-0.20 / -0.20%
  • Shares traded475.40k
  • 1 Year change-49.77%
  • Beta0.9451
Data delayed at least 15 minutes, as of Jun 30 2025 15:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year GN Store Nord A/S grew net income 333.33% from 228.00m to 988.00m despite relatively flat revenues.
Gross margin53.76%
Net profit margin4.99%
Operating margin9.15%
Return on assets2.97%
Return on equity7.77%
Return on investment4.78%
More ▼

Cash flow in DKKView more

In 2024, cash reserves at GN Store Nord A/S fell by 1.18bn. However, the company earned 2.73bn from its operations for a Cash Flow Margin of 15.15%. In addition the company used 1.54bn on investing activities and also paid 2.37bn in financing cash flows.
Cash flow per share15.61
Price/Cash flow per share6.48
Book value per share73.84
Tangible book value per share-43.77
More ▼

Balance sheet in DKKView more

GN Store Nord A/S has a Debt to Total Capital ratio of 52.26%, a higher figure than the previous year's 31.99%.
Current ratio1.13
Quick ratio0.8003
Total debt/total equity1.09
Total debt/total capital0.5226
More ▼

Growth rates in DKK

Year on year, growth in earnings per share excluding extraordinary items increased 313.35%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.22%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-9.20
EPS (TTM) vs
TTM 1 year ago		49.31
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.